This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Poland, Romania, United States
The drug TUKYSA contains one active pharmaceutical ingredient (API):
1
Tucatinib
UNII 234248D0HH - TUCATINIB
|
Tucatinib is a tyrosine kinase inhibitor of HER2. It is used in combination with trastuzumab and capecitabine for treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TUKYSA Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
TUKYSA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L01EH03 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02499827, 02499835 |
Country: EE | Ravimiamet | Identifier(s): 1842544, 1842555, 1862647 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1201526001, 1201526002 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 037635, 408097 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61156829, 69401038 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9038, 9039 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1092085, 1092086 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100448401, 100448418 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W69027001, W69028001 |
Country: US | FDA, National Drug Code | Identifier(s): 51144-001, 51144-002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.